Home > Insider Trading > Filing (0001829126-22-008372)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1642380	Oncocyte Corp	OCX	()	DE

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1590144	Pura Vida Investments, Llc	512 W 22Nd Street 7Th Floor New York NY 10011		No	No	Yes	No
1789193	Efrem Kamen	C/O Pura Vida Investments, Llc 888 7Th Avenue, 6Th Floor New York NY 10106		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-04-14	1,665,898	$1.33	7,350,447	No	4	P	Indirect	By Pura Vida Master Fund, Ltd.
Common Stock	Acquisiton	2022-04-14	30,790	$1.23	7,381,237	No	4	P	Indirect	By Pura Vida Master Fund, Ltd.
Common Stock	Acquisiton	2022-04-14	92,370	$1.26	7,473,607	No	4	P	Indirect	By Pura Vida Master Fund, Ltd.
Common Stock	Acquisiton	2022-04-14	1,916,419	$1.33	8,455,823	No	4	P	Indirect	By the Managed Accounts
Common Stock	Acquisiton	2022-04-14	19,210	$1.23	8,475,033	No	4	P	Indirect	By the Managed Accounts
Common Stock	Acquisiton	2022-04-14	57,630	$1.26	8,532,663	No	4	P	Indirect	By the Managed Accounts
Common Stock	Acquisiton	2022-04-14	767,952	$1.33	767,952	No	4	P	Indirect	By Pura Vida X Fund LP
Common Stock	Acquisiton	2022-04-14	1,381,438	$1.33	1,381,438	No	4	P	Indirect	By the Retirement Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Pura Vida Master Fund, Ltd.
No	4	P	Indirect	By Pura Vida Master Fund, Ltd.
No	4	P	Indirect	By Pura Vida Master Fund, Ltd.
No	4	P	Indirect	By the Managed Accounts
No	4	P	Indirect	By the Managed Accounts
No	4	P	Indirect	By the Managed Accounts
No	4	P	Indirect	By Pura Vida X Fund LP
No	4	P	Indirect	By the Retirement Trust

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant to purchase common stock	Acquisiton	2022-04-14	832,949	$0.00	832,949	$1.53
Common Stock	Warrant to purchase common stock	Acquisiton	2022-04-14	383,976	$0.00	383,976	$1.53
Common Stock	Warrant to purchase common stock	Acquisiton	2022-04-14	690,719	$0.00	690,719	$1.53
Common Stock	Warrant to purchase common stock	Acquisiton	2022-04-14	958,209	$0.00	958,209	$1.53

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
832,949	2022-04-19	2027-04-19	No	4	P	Indirect
383,976	2022-04-19	2027-04-19	No	4	P	Indirect
690,719	2022-04-19	2027-04-19	No	4	P	Indirect
958,209	2022-04-19	2027-04-19	No	4	P	Indirect

Footnotes

Each share of common stock was purchased together with one warrant to purchase 0.5 shares of common stock at a combined offering price of $1.3325.
Shares reported herein are owned by Pura Vida Master Fund, Ltd. (the "Pura Vida Master Fund"), Pura Vida X Fund LP (the "Pura Vida X Fund"), Lockheed Martin Corporation Master Retirement Trust (the "Retirement Trust"), and certain separately managed accounts (the "Managed Accounts," collectively the "Client Accounts"). Pura Vida Investments, LLC ("PVI") serves as the investment manager or sub-adviser to the Client Accounts. Efrem Kamen serves as the Managing Member of PVI.
By virtue of these relationships, the Reporting Persons may be deemed to have shared voting and dispositive power with respect to the securities owned directly by the Client Accounts. This report shall not be deemed an admission that the Reporting Persons are beneficial owners of the securities for purposes of Sections 13 and 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of the Reporting Person's pecuniary interest therein, if any.
The Warrants are subject to an ownership blocker provision that prevents the holder from exercising the Warrants if it would beneficially hold more than 19.99% of the common stock following such exercise.